Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic reviewAlan Kaplan,J. Mark Fitzgerald,Georges El Azzi,Michael Engel,Roland BuhlEUROPEAN RESPIRATORY JOURNAL（2018）引用 1|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
